1
All IDC research is © 2016 by IDC. All rights reserved. All IDC materials are licensed with IDC's permission and in no way does the use or publication of IDC research indicate IDC's endorsement of Dassault Systèmes’s products/or strategies. An IDC Infographic, sponsored by Dassault Systèmes Life Science Companies Face Major Challenges… …And Success Requires Operational Excellence Leading life science innovators deal with constant change and need to transform the way they work to succeed. Data access, collaboration, and standardization – the foundation for operational excellence – are key to success. Blockbuster patent expirations and regaining long-term sustainability fuel the pursuit of more efficient drug R&D. Enterprises can achieve this goal by focusing on: Transparently accessing and using data effec- tively from ideation to commercialization improves productivity, reduces waste, and speeds time to market. Collaboration is at the core of industry transformation, requiring more effective information sharing, agile infrastructure, and robust data security and regulatory compliance controls, while concurrently encouraging insight and innovation. $2.6 Billion Average cost to bring a new drug to market 10+ Years Average time from drug discovery to commercialization 2 out of 10 Drugs generate revenue to cover development costs Sources: Tufts Center for the Study of Drug Development, 2014; PhRMA, 2015 Source: IDC Research 1. Data Access 2. Collaboration Effectively leveraging today's data explosion requires standardized data management and processes across the R&D lifecycle. 3. Standardization Top investment areas for growth: • Improving collaboration capabilities • Better use of data through analytics • Improving idea management and innovation Data lakes, cloud-based solutions, Hadoop schema on read, and in-database analytics are being considered to address life science/healthcare data queries ANALYSES NEED TO BE TRANSPARENTLY STANDARDIZED IMPLEMENTATION OF AN OPEN FLEXIBLE PLATFORM IMPROVES COLLABORATION Cost of not finding information per employee, per year In the life sciences, less than 10% of new data generated is ever analyzed. Life science companies are actively looking for ways to better share research and improve collaborations with external partners. Business Benefits of Operational Excellence ✔ Direct cost savings ✔ Increased efficiency in drug discovery ✔ Reduced deviations from optimal product development processes ✔ More effective data utilization ✔ Reduced R&D risk ✔ Faster time to revenue The Takeaway Effective use of data, information, and knowledge across the life science value chain is key to operationalizing excellence. Process, technology, and scientific advances are transforming a discovery-centric industry into one where the complete scientific product lifecycle is actively managed and business metrics are leveraged. For more information, download the IDC White Paper, "Operationalizing Excellence in Life Sciences Through Data Access, Collaboration, and Standardization," sponsored by Dassault Systèmes. of life science companies are moving from individual, separate applications to comprehensive platform solutions. 70% Source: IDC Research of all R&D experiments are needlessly repeated 40% $5,900 3 Keys to Operationalizing Excellence in the Life Sciences Source: IDC Research
